Arcutis Biotherapeutics, Inc.

ARQT

Arcutis Biotherapeutics, Inc.

ARQT

Insider Sentiment (TTM):

Last Purchase:2025-06-13Last Sale:2026-06-17Shares Purchased (TTM):0Shares Sold (TTM):637,638

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:130,328,875Shares Outstanding:129,365,000Institutional Ownership Pct.:100.75%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents Fair Value Disclosure	35	43	47	73	53	71	135	84	190	88	107	105
Restricted Cash And Cash Equivalents	0	0	0	0	1	1	1	1	1	1	1	1
Available For Sale Securities Debt Securities Curr…	189	178	144	118	145	157	196	278	214	183	120	164
Accounts Receivable Net Current	144	146	115	107	85	73	60	43	37	26	19	17
Inventory Net	37	23	22	16	17	15	14	14	13	13	14	10
Prepaid Expense And Other Assets Current	32	21	20	19	23	20	18	14	13	19	20	12
Assets Current	438	411	349	333	324	336	424	435	468	330	282	309
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	2	2	2
Intangible Assets Net Excluding Goodwill	14	15	15	16	17	9	10	6	6	6	7	7
Operating Lease Right Of Use Asset	4	4	5	2	2	2	2	2	2	2	2	3
Other Assets Noncurrent	2	1	1	1	1	1	1	1	1	1	1	1
Assets	460	433	371	352	344	349	437	445	479	341	293	321
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	18	13	6	15	25	14	19	8	13	12	13	17
Long Term Debt Current	8	1	1	1	-	0	100	-	-	-	-	-
Operating Lease Liability Current	-	0	-	-	1	1	1	1	1	1	1	1
Accrued Liabilities Current	137	116	93	88	66	67	53	43	34	34	28	19
Liabilities Current	163	130	100	104	91	81	172	51	47	47	42	37
Operating Lease Liability Noncurrent	5	5	5	2	2	3	3	3	3	3	4	4
Long Term Debt Noncurrent	101	108	107	107	108	107	105	204	203	202	201	200
Other Liabilities Noncurrent	0	0	0	0	0	1	0	0	0	1	-	-
Liabilities	270	243	213	213	201	191	281	258	254	253	246	240
Stockholders Equity
Preferred Stock Value	-	-	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,340	1,328	1,314	1,302	1,290	1,279	1,267	1,256	1,242	1,071	963	952
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	-0	-0	-0	-0	1	-0	-0	0	-0	-0
Retained Earnings Accumulated Deficit	-1,149	-1,138	-1,155	-1,163	-1,147	-1,122	-1,111	-1,070	-1,017	-982	-916	-871
Stockholders Equity	190	189	158	139	143	158	157	186	225	89	47	81
Liabilities And Stockholders Equity	460	433	371	352	344	349	437	445	479	341	293	321
Preferred Stock Par Or Stated Value Per Share	-	-	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	125	123	120	120	119	118	117	116	116	97	62	62
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	-	-	0	0	0	0	0	0	0	0	0	0
Shares Outstanding	125	123	120	120	119	118	117	116	116	97	62	62
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-11.21%	11.71%	13.16%	-	-	-	-	-	-	-	-	-
2025	-8.94%	-4.05%	3.77%	1.04%	14.39%	30.92%	18.20%	12.26%	3.61%	-17.77%	-9.18%	-21.07%
2024	-10.95%	29.03%	13.78%	8.14%	4.59%	-9.50%	34.99%	48.03%	43.37%	39.43%	6.64%	15.66%
2023	-44.67%	-35.70%	-26.72%	-8.85%	-45.98%	-76.25%	-16.80%	21.31%	33.20%	-9.60%	-14.39%	-13.45%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.68	3.17	3.50	3.20	3.55	4.15	2.46	8.46	9.89	7.08	6.72	8.43
Quick Ratio	2.26	2.83	3.07	2.87	3.12	3.72	2.27	7.92	9.34	6.40	5.91	7.82
Working Capital	274.85M	281.39M	249.45M	228.84M	232.54M	254.81M	251.29M	383.24M	420.75M	283.76M	239.66M	272.21M
Leverage & Debt
Debt to Equity	1.43	1.29	1.35	1.54	1.41	1.21	1.79	1.39	1.13	2.85	5.27	2.98
Interest Coverage TTM	0.24	-1.01	-2.61	-4.71	-5.35	-4.73	-6.19	-5.94	-6.52	-8.11	-8.60	-12.07
Debt Ratio	0.59	0.56	0.57	0.61	0.59	0.55	0.64	0.58	0.53	0.74	0.84	0.75
Efficiency & Turnover
Asset Turnover TTM	1.03	0.95	0.78	0.65	0.51	0.48	0.30	0.19	0.11	0.07	0.05	0.04
Days Sales Outstanding TTM	101.39	107.56	101.87	105.58	107.12	108.35	131.11	149.37	189.91	214.26	214.13	558.92
Receivables Turnover TTM	3.60	3.39	3.58	3.46	3.41	3.37	2.78	2.44	1.92	1.70	1.70	0.65
Per Share Metrics
Diluted EPS TTM	-0.02	-0.13	-0.33	-0.73	-1.03	-1.16	-1.57	-1.61	-1.96	-1.89	-2.17	-2.69
Free Cash Flow Per Share TTM	0.21	-0.05	-0.30	-0.56	-0.93	-0.97	-1.35	-1.43	-1.79	-1.79	-2.13	-2.33
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	90.90%	90.14%	89.83%	88.93%	88.17%	88.51%	86.93%	86.30%	84.45%	82.91%	82.68%	79.42%
Operating Profit Margin TTM	0.78%	-3.29%	-12.18%	-33.08%	-58.09%	-77.10%	-164.34%	-242.73%	-409.51%	-826.08%	-1,333.74%	-2,813.92%
Net Profit Margin TTM	-0.57%	-4.34%	-14.12%	-35.95%	-62.12%	-84.09%	-176.62%	-268.37%	-453.21%	-898.17%	-1,438.56%	-2,944.02%
Growth Metrics
Net Revenue Growth (1Y)	98.08%	123.41%	183.56%	250.33%	335.28%	470.62%	494.53%	559.09%	641.83%	691.81%	2,468.41%	-
Net Income Growth (1Y)	-98.17%	-88.47%	-77.33%	-53.07%	-40.34%	-46.58%	-27.01%	-39.92%	-33.56%	-15.83%	-13.80%	27.22%
EPS Growth (1Y)	-98.22%	-89.04%	-77.92%	-54.37%	-47.43%	-38.78%	-27.50%	-40.22%	-26.80%	-33.17%	-20.27%	6.49%
Valuation Metrics
P/E TTM	-1,282.76	-228.91	-54.28	-19.09	-15.20	-12.03	-5.91	-5.78	-5.06	-1.71	-2.45	-3.54
P/B TTM	16.07	19.50	15.22	12.81	13.82	10.70	7.38	6.16	4.89	5.05	14.03	14.54
P/S TTM	7.37	9.93	7.66	6.86	9.44	10.12	10.44	15.51	22.94	15.34	35.20	104.20
Market Cap	3.05B	3.69B	2.41B	1.78B	1.97B	1.68B	1.16B	1.15B	1.10B	447.71M	655.54M	1.17B
Enterprise Value	3.12B	3.76B	2.47B	1.82B	2.03B	1.72B	1.23B	1.27B	1.11B	560.19M	747.93M	1.26B
Calculated Values
Free Cash Flow TTM	26.92M	-6.31M	-38.24M	-71.32M	-116.69M	-117.30M	-167.80M	-177.02M	-198.66M	-247.49M	-262.42M	-286.08M
Net Debt	74.35M	65.74M	61.07M	35.00M	53.90M	35.25M	69.14M	118.92M	12.09M	112.48M	92.39M	93.73M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-06-17Sale

Owner: Welgus, Howard G.

Title: -

Shares: 635

Price/Share: $25.67

Value: $16,300.45

Shares Owned: 37,743

Relationship: Director

Ownership: Direct

2026-06-15Sale

Owner: Lin, Sue-Jean

Title: -

Shares: 4,946

Price/Share: $24.38

Value: $120,583.48

Shares Owned: 27,567

Relationship: Director

Ownership: Direct

2026-05-11Sale

Owner: Vairavan, Latha

Title: SVP Chief Financial Officer

Shares: 435

Price/Share: $21.05

Value: $9,156.75

Shares Owned: 85,978

Relationship: Officer

Ownership: Direct

2026-05-11Sale

Owner: Burnett, Patrick

Title: See Remarks

Shares: 222

Price/Share: $21.05

Value: $4,673.10

Shares Owned: 120,244

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Matsuda, Masaru

Title: See Remarks

Shares: 8,256

Price/Share: $23.44

Value: $193,520.64

Shares Owned: 126,689

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-17	Welgus, Howard G.	Director	-	Direct	Sale	635	25.67	$16,300.45	37,743	4
2026-06-15	Lin, Sue-Jean	Director	-	Direct	Sale	4,946	24.38	$120,583.48	27,567	4
2026-05-11	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	435	21.05	$9,156.75	85,978	4
2026-05-11	Burnett, Patrick	Officer	See Remarks	Direct	Sale	222	21.05	$4,673.10	120,244	4
2026-05-04	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	8,256	23.44	$193,520.64	126,689	4
2026-05-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	684	23.61	$16,149.24	120,466	4
2026-05-04	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	3,172	23.61	$74,890.92	720,755	4
2026-05-04	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	1,341	23.61	$31,661.01	86,413	4
2026-05-01	Welgus, Howard G.	Director	-	Direct	Sale	7,144	22.99	$164,240.56	32,600	4
2026-04-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	23.88	$238,800.00	39,744	4
2026-03-02	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	3,687	25.54	$94,165.98	175,178	4
2026-03-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	25.65	$256,500.00	49,744	4
2026-03-02	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	37,349	25.54	$953,893.46	785,957	4
2026-03-02	Burnett, Patrick	Officer	See Remarks	Direct	Sale	6,287	25.54	$160,569.98	121,150	4
2026-03-02	Leonard, Keith R	Director	-	Direct	Sale	39,272	25.39	$997,116.08	22,123	4
2026-03-02	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	2,853	25.54	$72,865.62	87,754	4
2026-03-02	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	8,733	25.59	$223,477.47	136,932	4
2026-02-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	9,794	25.81	$252,783.14	80,651	4
2026-02-02	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	2,052	25.50	$52,326.00	148,865	4
2026-02-02	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	19,833	25.50	$505,741.50	721,306	4
2026-02-02	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	40,638	25.34	$1,029,766.92	110,003	4
2026-02-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	25.05	$250,500.00	59,744	4
2026-02-02	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	1,320	25.50	$33,660.00	63,607	4
2026-01-05	Burnett, Patrick	Officer	See Remarks	Direct	Sale	2,490	28.98	$72,160.20	94,120	4
2026-01-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	28.96	$289,600.00	69,744	4
2025-12-31	Burnett, Patrick	Officer	See Remarks	Direct	Sale	1,697	29.10	$49,382.70	96,610	4
2025-12-15	Burnett, Patrick	Officer	See Remarks	Direct	Sale	11,500	28.94	$332,810.00	98,307	4
2025-12-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	30.21	$302,100.00	79,744	4
2025-12-01	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	1,657	30.23	$50,091.11	150,641	4
2025-11-24	Lin, Sue-Jean	Director	-	Direct	Sale	25,272	30.78	$777,872.16	26,735	4
2025-11-24	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	48,945	30.36	$1,485,970.20	740,537	4
2025-11-20	Gilbert, Halley E	Director	-	Direct	Sale	16,532	27.55	$455,456.60	22,123	4
2025-11-19	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	2,550	28.22	$71,961.00	151,476	4
2025-11-13	Krishnamohan, Neha	Director	-	Direct	Sale	40,504	23.28	$942,933.12	22,123	4
2025-11-06	Burnett, Patrick	Officer	See Remarks	Direct	Sale	17,250	24.18	$417,105.00	98,325	4
2025-11-06	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	29,131	25.16	$732,935.96	150,193	4
2025-11-05	Burnett, Patrick	Officer	See Remarks	Direct	Sale	3,864	23.72	$91,654.08	98,325	4
2025-11-03	Welgus, Howard G.	Director	-	Direct	Sale	10,000	25.27	$252,700.00	89,744	4
2025-11-03	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	7,208	25.06	$180,632.48	154,026	4
2025-11-03	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	11,547	25.06	$289,367.82	794,893	4
2025-11-03	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	88	24.72	$2,175.36	64,927	4
2025-10-28	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	40,000	25.03	$1,001,200.00	806,440	4
2025-10-02	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	20,739	20.04	$415,609.56	846,440	4
2025-10-02	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	4,504	20.38	$91,791.52	178,897	4
2025-10-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	18.92	$189,200.00	99,744	4
2025-09-09	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	504	17.52	$8,830.08	891,440	4
2025-09-04	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	36,130	16.16	$583,860.80	161,234	4
2025-09-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	15.64	$156,400.00	100,206	4
2025-08-21	Burnett, Patrick	Officer	See Remarks	Direct	Sale	2,438	15.57	$37,959.66	104,811	4
2025-08-08	Burnett, Patrick	Officer	See Remarks	Direct	Sale	3,847	14.03	$53,973.41	108,999	4
2025-08-04	Watanabe, Todd	Director,Officer	See Remarks	Direct	Sale	11,547	14.33	$165,468.51	901,569	4
2025-08-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	2,622	14.33	$37,573.26	112,846	4
2025-08-04	Vairavan, Latha	Officer	SVP Chief Financial Officer	Direct	Sale	89	14.33	$1,275.37	65,015	4
2025-08-04	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	6,330	14.33	$90,708.90	197,364	4
2025-08-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	14.30	$143,000.00	100,206	4
2025-07-14	Burnett, Patrick	Officer	See Remarks	Direct	Sale	5,750	15.07	$86,652.50	115,468	4
2025-07-01	Welgus, Howard G.	Director	-	Direct	Sale	9,208	13.84	$127,438.72	100,206	4
2025-06-18	Welgus, Howard G.	Director	-	Direct	Sale	10,139	13.37	$135,558.43	109,414	4
2025-06-13	Heron, Patrick J	Director	-	Indirect	Purchase	2,646	13.08	$34,609.68	27,448	4
2025-06-05	Heron, Patrick J	Director	-	Indirect	Purchase	378	13.41	$5,068.98	24,802	4
2025-05-28	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	1,800	13.78	$24,804.00	202,599	4
2025-05-22	Heron, Patrick J	Director	-	Indirect	Purchase	2,520	13.65	$34,398.00	22,534	4
2025-05-19	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	7,451	14.07	$104,835.57	183,104	4
2025-05-15	Heron, Patrick J	Director	-	Indirect	Purchase	2,520	13.62	$34,322.40	17,494	4
2025-05-14	Heron, Patrick J	Director	-	Indirect	Purchase	6,300	13.76	$86,688.00	14,974	4
2025-05-09	Heron, Patrick J	Director	-	Indirect	Purchase	6,300	13.60	$85,680.00	6,300	4
2025-05-08	Burnett, Patrick	Officer	See Remarks	Direct	Sale	3,871	13.59	$52,606.89	115,468	4
2025-05-02	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	11,448	15.19	$173,895.12	913,795	4
2025-05-02	Burnett, Patrick	Officer	See Remarks	Direct	Sale	2,597	15.19	$39,448.43	119,339	4
2025-05-02	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	5,030	15.20	$76,456.00	204,399	4
2025-05-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	14.64	$146,400.00	111,944	4
2025-04-02	Topper, David Joseph	Officer	Chief Financial Officer	Direct	Sale	9,600	15.80	$151,680.00	182,774	4
2025-04-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	15.12	$151,200.00	121,944	4
2025-03-25	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	2,171	17.56	$38,122.76	925,243	4
2025-03-17	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	1,200	17.61	$21,132.00	928,914	4
2025-03-14	Burnett, Patrick	Officer	See Remarks	Direct	Sale	12,242	15.04	$184,119.68	121,936	4
2025-03-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	954	13.28	$12,669.12	166,089	4
2025-03-04	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	4,135	13.28	$54,912.80	930,114	4
2025-03-03	Welgus, Howard G.	Director	-	Direct	Sale	10,000	13.00	$130,000.00	131,944	4
2025-03-03	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	3,263	13.03	$42,516.89	209,429	4
2025-02-03	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	19,301	12.70	$245,122.70	804,129	4
2025-02-03	Burnett, Patrick	Officer	See Remarks	Direct	Sale	12,116	12.70	$153,873.20	114,862	4
2025-02-03	Welgus, Howard G.	Director	-	Direct	Sale	10,000	12.71	$127,100.00	141,944	4
2025-02-03	Edwards, Larry Todd	Officer	See Remarks	Direct	Sale	2,173	12.70	$27,597.10	135,555	4
2025-02-03	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	8,338	12.70	$105,892.60	178,692	4
2025-01-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	14.67	$146,700.00	151,944	4
2024-12-31	Burnett, Patrick	Officer	See Remarks	Direct	Sale	1,691	14.00	$23,674.00	126,978	4
2024-12-20	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	15,000	15.17	$227,550.00	823,430	4
2024-12-02	Welgus, Howard G.	Director	-	Direct	Sale	10,000	12.51	$125,100.00	161,944	4
2024-11-30	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Purchase	2,038	7.11	$14,490.18	838,430	4
2024-11-30	Matsuda, Masaru	Officer	See Remarks	Direct	Purchase	1,657	7.11	$11,781.27	187,030	4
2024-11-30	Edwards, Larry Todd	Officer	See Remarks	Direct	Purchase	1,093	7.11	$7,771.23	137,728	4
2024-11-22	Burnett, Patrick	Officer	See Remarks	Direct	Sale	16,023	10.14	$162,473.22	128,669	4
2024-11-19	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	1,775	9.68	$17,182.00	181,373	4
2024-11-15	Burnett, Patrick	Officer	See Remarks	Direct	Sale	100	10.03	$1,003.00	128,669	4
2024-11-11	Curran, Terrie	Director	-	Direct	Sale	8,687	10.85	$94,253.95	10,139	4
2024-11-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	15,441	8.68	$134,027.88	179,418	4
2024-11-04	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	13,871	8.68	$120,400.28	832,392	4
2024-11-04	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	5,015	8.68	$43,530.20	178,273	4
2024-11-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	8.65	$86,500.00	171,944	4
2024-10-02	Edwards, Larry Todd	Officer	SVP Chief Commercial Officer	Direct	Sale	3,725	10.01	$37,287.25	136,635	4
2024-10-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	9.26	$92,600.00	181,944	4
2024-09-24	Topper, David Joseph	Officer	Chief Financial Officer	Direct	Sale	11,626	9.48	$110,214.48	158,374	4
2024-09-03	Welgus, Howard G.	Director	-	Direct	Sale	10,000	10.77	$107,700.00	191,944	4
2024-08-19	Burnett, Patrick	Officer	See Remarks	Direct	Sale	1,728	8.29	$14,325.12	194,859	4
2024-08-02	Burnett, Patrick	Officer	See Remarks	Direct	Sale	13,206	9.02	$119,118.12	196,587	4
2024-08-02	Matsuda, Masaru	Officer	See Remarks	Direct	Sale	5,220	9.02	$47,084.40	183,288	4
2024-08-02	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	14,487	9.02	$130,672.74	846,263	4
2024-08-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	9.87	$98,700.00	176,953	4
2024-07-01	Welgus, Howard G.	Director	-	Direct	Sale	10,000	9.31	$93,100.00	180,339	4
2024-06-04	Welgus, Howard G.	Director	-	Direct	Sale	10,000	8.00	$80,000.00	170,200	4
2024-05-30	Burnett, Patrick	Officer	See Remarks	Direct	Sale	23,000	8.75	$201,250.00	209,793	4
2024-05-28	Matsuda, Masaru	Officer	See Remark	Direct	Sale	1,775	9.01	$15,992.75	188,508	4
2024-05-17	Edwards, Larry Todd	Officer	SVP Chief Commercial Officer	Direct	Sale	7,640	8.98	$68,607.20	140,360	4
2024-05-02	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	13,783	8.74	$120,463.42	860,750	4
2024-05-02	Moore, Matthew Richard	Officer	SVP and Chief Business Officer	Direct	Sale	4,681	8.74	$40,911.94	145,505	4
2024-05-02	Burnett, Patrick	Officer	See Remarks	Direct	Sale	9,555	8.74	$83,510.70	259,745	4
2024-05-02	Matsuda, Masaru	Officer	See Remark	Direct	Sale	5,016	8.74	$43,839.84	185,408	4
2024-03-04	Moore, Matthew Richard	Officer	SVP and Chief Business Officer	Direct	Sale	3,468	11.12	$38,564.16	146,020	4
2024-03-04	Burnett, Patrick	Officer	See Remarks	Direct	Sale	4,782	11.12	$53,175.84	269,300	4
2024-03-04	Matsuda, Masaru	Officer	See Remark	Direct	Sale	3,760	11.12	$41,811.20	190,424	4
2024-03-04	Heron, Patrick J	Director	-	Indirect	Purchase	21,052	9.50	$199,994.00	8,785,284	4
2024-03-04	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	14,903	11.12	$165,721.36	874,533	4
2024-02-28	Watanabe, Todd Franklin	Director,Officer	See Remarks	Direct	Sale	2,465	10.60	$26,129.00	889,436	4
2024-01-02	Burnett, Patrick	Officer	See Remarks	Direct	Sale	1,325	3.54	$4,690.50	57,032	4
2023-11-21	Matsuda, Masaru	Officer	See Remark	Direct	Sale	1,850	1.98	$3,663.00	46,634	4
2023-10-24	Fhm, Life Sciences Viii, …	TenPercentOwner	-	Direct	Purchase	80,000	2.50	$200,000.00	8,764,232	4
2023-08-21	Burnett, Patrick	Officer	See Remarks	Direct	Sale	1,605	7.04	$11,299.20	58,357	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

100.75%

Inst. Shares: 130,328,875

Shares Outstanding: 129,365,000

2025-12-31

99.20%

Inst. Shares: 126,222,456

Shares Outstanding: 127,234,000

2025-09-30

96.98%

Inst. Shares: 123,774,111

Shares Outstanding: 127,622,860

2025-06-30

97.84%

Inst. Shares: 124,257,674

Shares Outstanding: 126,997,000

2025-03-31

96.50%

Inst. Shares: 121,628,851

Shares Outstanding: 126,037,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	130,328,875	129,365,000	100.75%
2025-12-31	126,222,456	127,234,000	99.20%
2025-09-30	123,774,111	127,622,860	96.98%
2025-06-30	124,257,674	126,997,000	97.84%
2025-03-31	121,628,851	126,037,000	96.50%
2024-12-31	125,990,026	120,958,000	104.16%
2024-09-30	124,785,132	124,302,317	100.39%
2024-06-30	122,219,598	123,481,000	98.98%
2024-03-31	122,165,846	111,048,525	110.01%
2023-12-31	98,108,091	138,610,974	70.78%
2023-09-30	64,393,229	123,454,556	52.16%
2023-06-30	69,188,687	122,861,240	56.31%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Arcutis Biotherapeutics, Inc. (ARQT) — SEC Financial Statements & Analysis

Arcutis Biotherapeutics, Inc. (ARQT) is a pharmaceutical preparations company, incorporated in DE. Arcutis Biotherapeutics, Inc. trades on ARQT: Nasdaq as: ARQT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Arcutis Biotherapeutics, Inc. reported a 98.08% year-over-year revenue growth, a Gross Profit Margin of 90.90% (TTM), a Debt-to-Equity ratio of 1.43x, a Price-to-Sales (P/S) ratio of 7.37x (TTM), a Price-to-Book (P/B) ratio of 16.07 (TTM), at a market cap of $3.05B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 98.08%
Gross Profit Margin TTM: 90.90%
Debt To Equity: 1.43x
P/S TTM: 7.37x
P/B TTM: 16.07
Market Cap: $3.05B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Arcutis Biotherapeutics, Inc. in?

Arcutis Biotherapeutics, Inc. (ARQT) operates in the Pharmaceutical Preparations industry.

What is ARQT's market cap?

Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalization of $3.05B as of 2026-03-31.

What exchange does ARQT trade on?

Arcutis Biotherapeutics, Inc. (ARQT) trades on the ARQT: Nasdaq.

Where is Arcutis Biotherapeutics, Inc. incorporated?

Arcutis Biotherapeutics, Inc. is incorporated in DE.

Arcutis Biotherapeutics, Inc. (ARQT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.